Viewing Study NCT04698850


Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2025-12-28 @ 6:25 PM
Study NCT ID: NCT04698850
Status: WITHDRAWN
Last Update Posted: 2022-08-10
First Post: 2021-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation
Sponsor: Faculty Hospital Kralovske Vinohrady
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module